Grunberger George, Sze David, Ermakova Anastasia, Sieradzan Ray, Oliveria Teresa, Miller Eden M
Grunberger Diabetes Institute, Bloomfield Hills, MI.
Becton Dickinson and Company, Franklin Lakes, NJ.
Clin Diabetes. 2020 Jan;38(1):47-55. doi: 10.2337/cd19-0008.
An online survey was conducted to assess the perspectives and use of diabetes technologies by a sample of U.S. primary care physicians (PCPs) and endocrinologists to optimize intensive insulin therapy in patients with type 2 diabetes. Overall, endocrinologists reported using diabetes technologies more frequently than PCPs for patients with type 2 diabetes requiring basal-bolus insulin therapy. PCPs and endocrinologists who were highly focused on diabetes management with insulin therapy reported using insulin delivery devices (insulin pumps and wearable tube-free patches) when patients are not achieving their A1C target while taking basal plus three or more prandial injections of insulin daily.
开展了一项在线调查,以评估美国初级保健医生(PCP)和内分泌科医生对糖尿病技术的看法及使用情况,旨在优化2型糖尿病患者的强化胰岛素治疗。总体而言,对于需要基础-餐时胰岛素治疗的2型糖尿病患者,内分泌科医生报告使用糖尿病技术的频率高于初级保健医生。高度关注胰岛素治疗糖尿病管理的初级保健医生和内分泌科医生报告称,当患者在每日使用基础胰岛素加三次或更多次餐时胰岛素注射的情况下仍未达到糖化血红蛋白(A1C)目标时,会使用胰岛素输送设备(胰岛素泵和无管可穿戴贴片)。